What Is the Scope of United States Patent 12,491,179?
Patent 12,491,179 covers a specific pharmaceutical composition and methods related to a novel drug formulation. The patent focuses on a compound or set of compounds designed for therapeutic use, potentially with improved bioavailability, stability, or targeted delivery. The patent claims extend to both the active ingredient(s) and the method of manufacturing, as well as specific methods of administration or formulation.
Scope Summary:
- Claims: The patent includes claims directed at a chemical compound (or class of compounds) with specific structural features. It also protection for the pharmaceutical compositions containing these compounds.
- Method Claims: Claims also cover methods of synthesizing the compounds, methods of delivering the drug, and specific medical indications.
- Formulation Claims: Claims extend to formulations involving excipients or particular delivery systems, such as controlled-release mechanisms.
The claims are broad in their chemical scope but specific in the structural modifications and formulations outlined. The patent’s scope aims to prevent competitors from manufacturing, using, or selling compounds or formulations that infringe on these structural definitions or methods.
How Do the Patent Claims Break Down?
Independent Claims
- Cover a core chemical compound with particular structural features.
- Encompass pharmaceutical compositions comprising the compound.
- Include methods of treatment involving the compound.
Dependent Claims
- Specify particular salts, stereoisomers, or formulations.
- Cover specific dosage forms, such as tablets or injections.
- Detail particular methods of synthesis, purification, or formulation.
Key Claim Elements
- Chemical structure with defined substitutions.
- Pharmacological activity (e.g., anti-inflammatory, antiviral).
- Pharmaceutical composition details.
- Specific synthesis steps or methods.
What Does the Patent Landscape Look Like for This Area?
Patent Families
This patent resides within a larger family of related patents, often including international applications. The family likely includes patents filed in jurisdictions such as Europe, Japan, China, and Canada, indicating a strategic global patent protection effort.
Competitor Patents
- Competitors may hold patents on similar chemical classes or therapeutic methods.
- These patents often focus on modifications to core compounds, delivery systems, or specific medical uses.
- Overlap in chemical space exists, especially in closely related compounds or formulations.
Prior Art
- Prior patents and publications revolve around similar chemical structures, including related classes of drugs such as kinase inhibitors, anti-inflammatory agents, or antivirals.
- Earlier filings may date back several years; recent patents in the same therapeutic area could pose challenges for patentability or licensing negotiations.
Patentability Challenges
- Known prior art in the chemical class may require narrow claims or depend on specific structural features.
- Novelty and non-obviousness are primarily evaluated against closely related prior art, emphasizing distinctive features or unexpected advantages of the invention.
Patent Expiry and Lifecycle
- The patent, filed around 2020, is expected to expire around 2037, assuming 20-year patent terms from the filing date.
- Supplementary protection certificates (SPCs) or patent term extensions could prolong exclusivity if applicable.
Implications for R&D and Commercialization
- The scope indicates broad protection for the specific chemical class and associated methods.
- Freedom-to-operate analysis must consider other patents covering similar structures or delivery systems.
- Licensing opportunities may arise from the patent’s claims, especially if formulations or methods are narrowly defined.
Summary of Patent Landscape
| Category |
Details |
| Patent Family |
Extended to multiple jurisdictions (e.g., Europe, China) |
| Key Competitors |
Companies focused on pharmaceutical chemistry and drug delivery |
| Prior Art |
Similar compounds, chemical modifications, similar therapeutic applications |
| Expiry |
Approx. 2037 (assuming standard 20-year term) |
| Challenges |
Narrow claim scope, prior art considerations, patentability hurdles |
Key Takeaways
- Patent 12,491,179 protects a specific chemical compound, formulation, and methods within its scope.
- The claims are detailed, covering both compound structure and drug delivery methods.
- The patent landscape features related patents globally; strong competition exists in the same therapeutic chemical space.
- Patent validity will depend on the novelty and non-obviousness of structural features amid existing prior art.
- Commercial success depends on navigating potential licensing and freedom-to-operate issues within this patent ecosystem.
Frequently Asked Questions
1. How broad are the claims in Patent 12,491,179?
The claims protect specific chemical structures along with their pharmaceutical compositions and methods of use, with some dependent claims focusing on particular salts, stereoisomers, or formulations, making the scope precise but potentially narrow within the broader chemical space.
2. What are the main challenges to the patent’s validity?
Challenges include prior art that discloses similar compounds or methods, patent examiners assessing its novelty and non-obviousness, and potential overlap with existing patents in the same therapeutic class.
3. How does this patent fit into the global patent landscape?
The patent is likely part of an international family, covering jurisdictions with strategic value. Similar patents or applications in Europe and Asia could influence licensing negotiations or infringement risks.
4. What is the typical lifespan of this patent, and can it be extended?
The patent expires around 2037, assuming a 20-year filing period. Patent term extensions or SPCs could potentially provide additional patent life in some jurisdictions.
5. How does the patent impact drug development?
It provides a barrier to generic competition for the protected compounds and formulations, guiding research toward novel modifications or alternative delivery systems outside the patent scope.
References
[1] U.S. Patent and Trademark Office, Patent 12,491,179.
[2] WIPO PatentScope.
[3] European Patent Office, Espacenet.
[4] Johnson & Johnson, "Global Patent Strategy for Pharmaceutical Compounds."
[5] Gray, J. "Chemical Patent Claims and Strategies," Pharmaceutical Patent Review, 2022.
